Cited by 101Gastroesophageal reflux and treatmentsGastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studies

The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux disease

Open access
NOJKOV, B., RUBENSTEIN, J. H., ADLIS, S. A., SHAW, M. J., SAAD, R., RAI, J., WEINMAN, B., CHEY, W. D.·2008·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background A subset of patients with gastro‐oesophageal reflux disease (GERD) does not achieve complete symptom resolution with proton pump inhibitor (PPI) therapy. The factors which affect response to PPI therapy in GERD patients remain unclear. Aims To determine the prevalence and impact of irritable bowel syndrome (IBS) and psychological distress (PD) on GERD symptoms and disease‐specific quality of life (QoL) before and after PPI therapy and to assess the same outcomes before and after PPI therapy in non‐erosive reflux disease (NERD) and erosive oesophagitis (EO) GERD patients. Methods Patients undergoing oesophago‐gastroduodenoscopy (OGD) for heartburn were recruited. Participants completed validated surveys: Digestive Health Symptom Index, Reflux Disease Questionnaire, Quality of Life in Reflux and Dyspepsia and Brief Symptom Inventory (BSI). IBS was defined as >3 Manning criteria and PD as BSI score >63. At OGD, patients were classified as NERD or EO. Patients were treated with rabeprazole 20 mg/day for 8 weeks before completing follow‐up surveys. Results Of 132 GERD patients enrolled, 101 completed the study. The prevalence rates of IBS and PD were 36% and 41%, respectively. IBS independently predicted worse QoL before and after PPI therapy. PD independently predicted worse GERD symptoms and QoL before and after PPI therapy. There were no differences in symptoms or QoL between NERD and EO patients before or after PPI therapy. Conclusions IBS and PD impacted GERD symptoms and QoL before and after PPI therapy. Symptoms and QoL before and after PPI therapy were similar in NERD and EO patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2008.03596.x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The concomitant presence of IBS or psychological distress in GERD patients predicted higher symptom ratings and lower quality of life before and after PPI treatment.

    “In addition, the concomitant presence of IBS or psychological distress in GERD patients predicted higher symptom ratings and lower quality of life before and after PPI treatment, making this subset of patients a therapeutic challenge.20”

    From Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes (2010) · cites this paper as [20]

    The ‘Impact of co-morbid PD on GERD symptoms and QoL’ section supports higher symptom burden and worse disease-specific quality of life before and after PPI therapy among patients with psychological distress. The ‘Impact of co-morbid IBS’ section supports higher symptoms and worse quality of life before treatment, but IBS was not associated with post-treatment symptom scores, and its lower post-treatment quality-of-life scores were not statistically significant. The claim overstates the post-treatment findings for IBS. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Another study found 36 percent prevalence of IBS in GERD patients.

    “Another study found 36 percent prevalence of IBS in GERD patients.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 42 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. Baker LH, Lieberman D, Oehlke M. Psy- chological distress in patients with gas- troesophageal reflux disease. Am J Gastroenterol 1995; 90: 1797-803.
  2. Carlsson R, Dent J, Watts R, et al. Gas- tro-esophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroentrol Hepatol 1998; 10: 119-24.
  3. Moayyedi P, Talley NJ. Gastroesopha- geal reflux disease. Lancet 2006; 367: 2086-100.

Cited by

Sorted by citations

Authors
NOJKOV, B., RUBENSTEIN, J. H., ADLIS, S. A., SHAW, M. J., SAAD, R., RAI, J., WEINMAN, B., & CHEY, W. D.
Affiliations
  • University of Michigan (US)
  • Park Nicollet Health Services (US)
Corresponding author
CHEY, W. D.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2008-01-10
Volume
27
Issue
6
Pages
473-482
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2136938649
Cited by
101
References
42
Citations by year
2025: 5 · 2024: 3 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 6 · 2014: 11 · 2013: 12 · 2012: 12
FWCI
9.75
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
  • Janssen Scientific Affairs
  • Eisai
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
Keywords
gastroesophageal reflux disease, irritable bowel syndrome, psychological distress, proton pump inhibitors, rabeprazole, non-erosive reflux disease, erosive esophagitis, quality of life, heartburn, treatment response, comorbidities
MeSH terms
Adolescent, Adult, Aged, Female, Gastroesophageal Reflux, Heartburn, Humans, Male, Middle Aged, Quality of Life, Stress, Physiological, Proton Pumps, Irritable Bowel Syndrome, 2-Pyridinylmethylsulfinylbenzimidazoles, Proton Pump Inhibitors, Rabeprazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review